powerballnumbersresults| Kedi-B (02487): Subsidiary obtained drug production license, expanded production capacity and market expansion

News summary

Kedi Biomedical (Wuxi) Co., Ltd., a wholly-owned subsidiary of Kedi-B(02487), won the "Drug Production License" issued by the Drug Administration of Jiangsu ProvincepowerballnumbersresultsThis move is expected to have a positive impact on the company's market expansion and production capacity increase.

Newsletter text

Kedi Biomedical Subsidiary Won "Drug Production License"

Biotechnology company Kedi-B (02487) recently announced thatpowerballnumbersresults, its wholly-owned subsidiary Kedi Biomedical (Wuxi) Co., Ltd. successfully obtained the "Drug Production License" issued by the Drug Administration of Jiangsu Province.

The issuance of this license is of great significance to Kedi Wuxi